Indexing
CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học
Abstract
Background:Stroke is a serious complication in patients with mechanical heart valves, caused either by thromboembolism or anticoagulation-related hemorrhage. Maintaining the international normalized ratio (INR) within the therapeutic range is crucial but remains challenging in clinical practice. Objective: To investigate the prevalence of stroke in patients with mechanical heart valves receiving vitamin K antagonists at Thanh Hoa General Hospital. Methods: A cross-sectional descriptive study was conducted on 430 patients with mechanical heart valves attending the outpatient clinic or admitted to Thanh Hoa General Hospital over a 22-month period (January 1, 2021 – October 31, 2022). Clinical examination, laboratory testing, and definitive diagnosis of stroke were performed. The prevalence of stroke and its associations with clinical factors were analyzed. Results: A total of 430 patients were enrolled, mean age 52.43 ± 9.33 years; males accounted for 39.1%. Mitral valve replacement was the most common (235; 54.65%), followed by combined mitral and aortic valve replacement (131; 30.47%) and isolated aortic valve replacement (64; 14.88%). The prevalence of ischemic stroke, hemorrhagic stroke, and transient ischemic attack was 4.9%, 2.6%, and 6.0%, respectively. Patients with hemorrhagic stroke had supra-therapeutic INR 1.74 times more frequently than those without hemorrhage (p<0.05). Sub-therapeutic or supra-therapeutic INR was not significantly associated with ischemic stroke or transient ischemic attack (p>0.05). Conclusion: The prevalence of ischemic stroke, hemorrhagic stroke, and transient ischemic attack among patients with mechanical heart valves was 4.9%, 2.6%, and 6.0%, respectively. Hemorrhagic stroke was significantly associated with supra-therapeutic INR values| Published | 2026-06-28 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 16 No. 3 (2026) | |
| Section | Original Articles | |
| DOI | 10.34071/jmp.2026.3.669 | |
| Keywords | đột quỵ não; nhồi máu não; xuất huyết não; van tim cơ học |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Hue Journal of Medicine and Pharmacy
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2014;63(22):e57-e185. doi:10.1016/j.jacc.2014.02.536
Piper C, Hering D, Langer C, Horstkotte D. Etiology of stroke after mechanical heart valve replacement-results from a ten-year prospective study. J Heart Valve Dis. 2008;17(4):413-417.
Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162-172. doi:10.1038/nrcardio.2010.202
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi:10.1093/eurheartj/ehab395
Tạ Mạnh Cường. Nghiên cứu so sánh sự ổn định về tác dụng chống đông của acenocoumarol và warfarin ở người mang van cơ học. Tạp Chí Tim Mạch Học Việt Nam. 2012;2(2).
Đỗ Quốc Hùng. So sánh việc sử dụng thuốc chống đông acenocoumarol và warfarin ở bệnh nhân thay van tim nhân tạo cơ học. Tạp Chí Học Việt Nam. (2):31-35.
Huckaby LV, Seese LM, Gleason TG, et al. Outcomes related to anticoagulation management for mechanical valve replacements. J Thorac Dis. 2021;13(5):2874-2884. doi:10.21037/jtd-20-2562
Mohamed H. Antithrombotic Therapy in Patients with Prosthetic Heart Valves. Libyan J Med. 2009;4(1):54-56. doi:10.4176/090115
Bouhout I, El-Hamamsy I. The Prospective Randomized On-X Valve Anticoagulation Clinical Trial (PROACT): Lower is better, but is it good enough? Glob Cardiol Sci Pract. 2019;2019(1):2. doi:10.21542/gcsp.2019.2
Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation. 1996;94(9):2107-2112. doi:10.1161/01.cir.94.9.2107
Horstkotte D, Bergemann R, Althaus U, et al. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve. J Heart Valve Dis. 1993;2(4):411-419.